SE389331B - Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. - Google Patents
Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.Info
- Publication number
- SE389331B SE389331B SE7204544A SE454472A SE389331B SE 389331 B SE389331 B SE 389331B SE 7204544 A SE7204544 A SE 7204544A SE 454472 A SE454472 A SE 454472A SE 389331 B SE389331 B SE 389331B
- Authority
- SE
- Sweden
- Prior art keywords
- methylendiphenols
- procedure
- preparation
- certain stated
- stated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7104839.A NL167151C (nl) | 1971-04-09 | 1971-04-09 | Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen. |
Publications (1)
Publication Number | Publication Date |
---|---|
SE389331B true SE389331B (sv) | 1976-11-01 |
Family
ID=19812895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7204544A SE389331B (sv) | 1971-04-09 | 1972-04-07 | Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. |
Country Status (19)
Country | Link |
---|---|
US (1) | US3884906A (fr) |
JP (2) | JPS5525177B1 (fr) |
AR (2) | AR194587A1 (fr) |
AU (1) | AU459272B2 (fr) |
BE (1) | BE781674A (fr) |
CH (2) | CH586182A5 (fr) |
DE (1) | DE2215409C3 (fr) |
DK (1) | DK143227C (fr) |
ES (1) | ES401501A1 (fr) |
FR (1) | FR2132788B1 (fr) |
GB (1) | GB1346266A (fr) |
HU (1) | HU165790B (fr) |
IE (1) | IE36209B1 (fr) |
IL (1) | IL39108A (fr) |
NL (1) | NL167151C (fr) |
PH (2) | PH15268A (fr) |
SE (1) | SE389331B (fr) |
SU (1) | SU580828A3 (fr) |
ZA (1) | ZA722331B (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4101678A (en) * | 1977-11-08 | 1980-05-01 | Ici Australia Ltd | Process for killing parasites |
FR2549476B1 (fr) * | 1983-07-20 | 1986-04-25 | Rech Ind | Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique |
US6403652B1 (en) | 2000-06-30 | 2002-06-11 | Colgate-Palmolive Company | Method and composition |
ES2387881T3 (es) * | 2004-03-16 | 2012-10-03 | Boehringer Ingelheim International Gmbh | Derivados de benceno sustituidos por glucopiranosilo, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparación |
UA91546C2 (uk) * | 2005-05-03 | 2010-08-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ |
US7772191B2 (en) * | 2005-05-10 | 2010-08-10 | Boehringer Ingelheim International Gmbh | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
PE20080697A1 (es) * | 2006-05-03 | 2008-08-05 | Boehringer Ingelheim Int | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion |
CL2008002427A1 (es) * | 2007-08-16 | 2009-09-11 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2. |
EP2217602B1 (fr) * | 2007-11-30 | 2018-08-29 | Boehringer Ingelheim International GmbH | Dérivés 1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one et leur utilisation comme modulateurs de pde9a pour le traitement de troubles cns |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
PE20110383A1 (es) | 2008-09-08 | 2011-07-15 | Boehringer Ingelheim Int | Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a) |
EP3711751A1 (fr) | 2009-02-13 | 2020-09-23 | Boehringer Ingelheim International GmbH | Composition pharmaceutique comprenant un inhibiteur de sglt2, un inhibiteur de dpp-iv et éventuellement un autre agent anti-diabète et ses utilisations |
BRPI1013638A2 (pt) * | 2009-02-13 | 2020-08-04 | Boehringer Ingelheim International Gmbh | composição farmacêutica que compreende derivados de glicopiranosildifenil-metano, sua forma de dosagem farmacêutica, processo para sua preparação, e seus usos para melhor controle glicèmico em um paciente |
WO2010112437A1 (fr) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Dérivés 1-hétérocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one et leur utilisation en tant que modulateurs de pde9a |
TW201118099A (en) * | 2009-08-12 | 2011-06-01 | Boehringer Ingelheim Int | New compounds for the treatment of CNS disorders |
EP2486029B1 (fr) * | 2009-09-30 | 2015-06-10 | Boehringer Ingelheim International GmbH | Procédés de préparation de dérivés de benzyl-benzène substitués par un glucopyranosyle |
WO2011039107A1 (fr) * | 2009-09-30 | 2011-04-07 | Boehringer Ingelheim International Gmbh | Procédé de préparation d'une forme cristalline de 1-chloro-4-(β-d-glucopyranos-1-yl)-2-[4-((s)-tétrahydrofuran-3-yloxy)-benzyl]-benzène |
US10610489B2 (en) * | 2009-10-02 | 2020-04-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
EP2603511B1 (fr) | 2010-08-12 | 2017-03-15 | Boehringer Ingelheim International GmbH | Dérivés 6-cycloalkyle-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de pde9a |
US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
AR085689A1 (es) | 2011-03-07 | 2013-10-23 | Boehringer Ingelheim Int | Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2 |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
US9192617B2 (en) | 2012-03-20 | 2015-11-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
ES2702174T3 (es) | 2013-04-05 | 2019-02-27 | Boehringer Ingelheim Int | Usos terapéuticos de empagliflozina |
US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
MX2021004308A (es) | 2013-04-18 | 2022-10-26 | Boehringer Ingelheim Int | Empagliflozina para usarse en el tratamiento de micro y macroalbuminuria. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2544826A (en) * | 1945-05-08 | 1951-03-13 | Dow Chemical Co | Anthelmintic feed composition |
US2615052A (en) * | 1950-06-23 | 1952-10-21 | Allied Lab Inc | 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production |
US2739941A (en) * | 1952-09-13 | 1956-03-27 | Gen Aniline & Film Corp | Germicidal soap composition |
NL283922A (fr) * | 1962-10-03 |
-
1971
- 1971-04-09 NL NL7104839.A patent/NL167151C/xx not_active IP Right Cessation
-
1972
- 1972-03-21 IE IE364/72A patent/IE36209B1/xx unknown
- 1972-03-24 GB GB1405372A patent/GB1346266A/en not_active Expired
- 1972-03-29 DE DE2215409A patent/DE2215409C3/de not_active Expired
- 1972-03-29 US US239341A patent/US3884906A/en not_active Expired - Lifetime
- 1972-03-29 IL IL39108A patent/IL39108A/en unknown
- 1972-04-05 AR AR241303A patent/AR194587A1/es active
- 1972-04-05 BE BE781674A patent/BE781674A/fr not_active IP Right Cessation
- 1972-04-06 AU AU40850/72A patent/AU459272B2/en not_active Expired
- 1972-04-06 ES ES401501A patent/ES401501A1/es not_active Expired
- 1972-04-07 DK DK170572A patent/DK143227C/da not_active IP Right Cessation
- 1972-04-07 HU HUCE872A patent/HU165790B/hu unknown
- 1972-04-07 ZA ZA722331A patent/ZA722331B/xx unknown
- 1972-04-07 SE SE7204544A patent/SE389331B/xx unknown
- 1972-04-07 SU SU7201770201A patent/SU580828A3/ru active
- 1972-04-07 FR FR7212355A patent/FR2132788B1/fr not_active Expired
- 1972-04-07 PH PH13428A patent/PH15268A/en unknown
- 1972-04-08 JP JP3487172A patent/JPS5525177B1/ja active Pending
- 1972-04-10 CH CH524572A patent/CH586182A5/xx not_active IP Right Cessation
- 1972-04-10 CH CH1324975A patent/CH575372A5/xx not_active IP Right Cessation
-
1973
- 1973-02-26 AR AR246797A patent/AR193590A1/es active
-
1975
- 1975-02-24 PH PH16845A patent/PH14191A/en unknown
-
1978
- 1978-08-23 JP JP53101920A patent/JPS5950645B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE781674A (fr) | 1972-10-05 |
PH14191A (en) | 1981-03-26 |
AR193590A1 (es) | 1973-04-30 |
ZA722331B (en) | 1973-01-31 |
ES401501A1 (es) | 1975-02-16 |
DE2215409A1 (de) | 1973-01-25 |
DE2215409B2 (de) | 1980-02-14 |
FR2132788A1 (fr) | 1972-11-24 |
JPS557256A (en) | 1980-01-19 |
NL7104839A (fr) | 1972-10-11 |
JPS5525177B1 (fr) | 1980-07-04 |
PH15268A (en) | 1982-11-02 |
IL39108A0 (en) | 1972-05-30 |
NL167151B (nl) | 1981-06-16 |
AU4085072A (en) | 1973-10-11 |
DK143227B (da) | 1981-07-27 |
HU165790B (fr) | 1974-11-28 |
IE36209B1 (en) | 1976-09-15 |
SU580828A3 (ru) | 1977-11-15 |
GB1346266A (en) | 1974-02-06 |
FR2132788B1 (fr) | 1976-05-14 |
NL167151C (nl) | 1981-11-16 |
US3884906A (en) | 1975-05-20 |
CH575372A5 (fr) | 1976-05-14 |
CH586182A5 (fr) | 1977-03-31 |
DK143227C (da) | 1981-11-30 |
AU459272B2 (en) | 1975-03-05 |
JPS5950645B2 (ja) | 1984-12-10 |
AR194587A1 (es) | 1973-07-31 |
IL39108A (en) | 1976-04-30 |
DE2215409C3 (de) | 1980-10-09 |
IE36209L (en) | 1972-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE389331B (sv) | Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. | |
SE384211B (sv) | Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
FI55186B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1,4-dihydropyridinkarboxylsyraestrar | |
NO147916C (no) | Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser. | |
BG20336A3 (bg) | Метод за получаване на 3-карбомоил-2.4.6- трийдефинил-алкилетери | |
SE7505279L (sv) | Forfarande for framstellning av hydroxipyrimidiner. | |
BG19799A3 (bg) | Метод за получаване на 3,4-дихидро-2н-изохинолин-1-они | |
SE400768B (sv) | Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon | |
SE386175B (sv) | Forfarande for framstellning av 1,4-bis-acylpiperaziner | |
SE406587B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin | |
NO137093C (no) | Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner | |
SE394677B (sv) | Forfarande for framstellning av 4-hydroxi-2h-1-bensotiopyran-3-karboxanilid-1,1-dioxider | |
SE390025B (sv) | Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion | |
NO136046C (no) | Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner. | |
SE383521B (sv) | Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider). | |
SE400548B (sv) | Forfarande for framstellning av en substituerad bensoylester av en 1,8,9-trihydroxiantracen | |
NO136195C (no) | Fremgangsm}te ved fremstilling av 2,4-diamino-5-benzylpyrimidiner. | |
DK130308B (da) | Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener. | |
SE389103B (sv) | Forfarande for framstellning av 1,4-metano-och 1,4-etanotetrahydro | |
SE389335B (sv) | Forfarande for framstellning av vissa angivna ketaziner. | |
SE401366B (sv) | Forfarande for framstellning av 2,6-metano-3-bensazociner | |
DK131189B (da) | Analogifremgangsmåde til fremstilling af 16-hydroxylerede 17alfa-ethynyl-17beta-hydroxy-13beta-alkylgona-4,9,11-trien-3-oner. | |
DK134518B (da) | Analogifremgangsmåde til fremstilling af 4beta-alkoxy-4alfa-(3'-hydroxyphenyl)-3alfa,5alfa-propanopiperidin-derivater. | |
NO137940C (no) | Analogifremgangsmaate til fremstilling av 4`,5-dinitro-3`-trifluormetyl-2-tiofenanilid | |
SE394437B (sv) | Forfarande for framstellning av etyl-8-hydroxi-1,3-dioxolo (4,5g)kinolin-7-karboxylat |